It’s fair to say that the CBD market is thriving. According to market intelligence company Hemp Business Journal, $130 million worth of products containing the cannabinoid were bought in the U.S. in 2016. And that figure is only set to rise in the years to come, the data analyst believes. Indeed, the source estimates that consumer sales of CBD goods will total an astounding $2.1 billion by 2020 – buoyed, perhaps, by claims that the usage of such products can help alleviate the symptoms of chronic pain, depression and diabetes, to name but a few conditions.
Not all CBD is created equally. Some tinctures are created with little regard to overall consumer safety, and may contain harmful chemicals and pesticides. Other CBD products have been shown to differ from what the label says, either with way more cannabidiol, or way less. In some cases, the THC content was elevated above the federal legal limit for hemp extracts.
Spruce was founded by Tony Spencer, who had a clear mission for his company—give people access to safe and effective lab-grade, hemp-based CBD. Spencer realized that many other CBD oils on the market were low-potency and simply didn’t work. “We have a lot of customers in pain who have wasted money on CBD products in the past that didn’t work for them,” remarks Spruce on their website.